ESC Premium Access

Poster Session 2 - Chronic heart failure – Epidemiology, prognosis, outcome

Event: ESC Congress 2018
Topic: European Society of Cardiology, Other
Session type: Poster Session
Date: 26 August 2018

Congress Session

17 presentations in this session

The association between renin-angiotensin-aldosterone system inhibitors dose reduction and risk of mortality and major adverse cardiovascular events in heart failure patients

Speaker: Mr D. Ayoubkhani (Cardiff, GB)
Thumbnail

Longitudinal changes in troponin concentrations from mid- to late-life and left ventricular structure and function in late-life: The Atherosclerosis Risk in Community Study

Speaker: Doctor P. Myhre (Akershus, NO)
Thumbnail

One year follow-up of heart failure patients: role of the new TNM-like staging system

Speaker: Doctor M. Alfarano (Rome, IT)
Thumbnail

Incidence and prevalence of light chain amyloidosis: a population-based study

Speaker: Miss S. Duhamel (Bron, FR)
Thumbnail

Deaths and vascular outcomes with non-vitamin k oral anticoagulants versus warfarin in patients with heart failure in the food and drug administration adverse event reporting system

Speaker: Doctor T. Von Lueder (Oslo, NO)
Thumbnail

Prediction of sudden death in outpatients with heart failure: a bio-clinical approach.

Speaker: Doctor J. Lupon (Badalona, ES)
Thumbnail

The optimal cutoff value of free triiodothyronine level in patients with hypertrophic obstructive cardiomyopathy

Speaker: Doctor K. Zhang (Beijing, CN)
Thumbnail

Non-truncating Filamin C variants represent disease-causing mutations in dilated cardiomyopathy

Speaker: Doctor T. Schimerova (Prague, CZ)
Thumbnail

Resting heart rate in late adolescence and long term risk of early heart failure in Swedish men

Speaker: Doctor M. Lindgren (Gothenburg, SE)
Thumbnail

Impact of comorbidities on the predictive value of cardiac MIBG imaging in patients admitted for acute decompensated heart failure: a prospective comparative study

Speaker: Doctor K. Kayama (Osaka, JP)
Thumbnail

17 speakers from this session

Mr Daniel Ayoubkhani

Health Economics & Outcomes Research Ltd, Cardiff (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Peder Langeland Myhre

Akershus University Hospital, Akershus (Norway)
0 follower

Doctor Maria Alfarano

Sapienza University of Rome, Rome (Italy)
0 follower

Miss Suzanne Duhamel

Hospital Louis Pradel of Bron, Bron (France)
0 follower

Doctor Thomas Gero Von Lueder

Oslo University Hospital, Department of Cardiology, Oslo (Norway)
2 presentations
0 follower

Doctor Josep Lupon

Germans Trias i Pujol Hospital, Badalona (Spain)
0 follower

Doctor Kuo Zhang

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (China)
0 follower

Doctor Tereza Schimerova

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)
0 follower

Doctor Martin Lindgren

Sahlgrenska Academy, Gothenburg (Sweden)
0 follower

Doctor Kiyomi Kayama

Osaka General Medical Center, Osaka (Japan)
0 follower

Mrs Bochra Zareini

Gentofte University Hospital, Copenhagen (Denmark)
0 follower

Doctor Shirley Sze

Cardiovascular Research Unit of Leicester, Leicester (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Gustavo Salgado Duque

State University of Rio de Janeiro (UERJ), Rio de Janeiro (Brazil)
0 follower

Doctor Shirley Sze

Cardiovascular Research Unit of Leicester, Leicester (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Kiyomi Kayama

Osaka General Medical Center, Osaka (Japan)
0 follower

Assistant Professor Caterina Delcea

University of Medicine and Pharmacy Carol Davila, Bucharest (Romania)
0 follower

Doctor Robbie Murphy

University College Cork, Cork (Ireland)
0 follower

This platform is supported by

logo Novo Nordisk